Table 3.
Factors predictive of relapse |
---|
Reflective of disease activity at de-escalation or during follow-up |
• Elevated inflammatory markers (elevated leukocyte count,34, 41 elevated CRP,24, 31, 34 escalation,51, 52 elevated FC25, 34, 41 |
• Laboratorial markers suggestive of ongoing inflammation (low hemoglobin)34 |
• Absence of mucosal healing24, 34 |
Factors reflective of disease poor prognostic features |
• Smoking29, 31 |
• Perianal disease29 |
• Disease location (ileocolonic disease35; colonic versus ileal or ileocolonic disease46) |
• Young age at diagnosis41, 42 |
Previous disease course |
• Prior disease course marked by higher therapeutic requirements (higher steroid use,34 prior anti-TNF course*,31, 35, 49 need for dose-escalation prior to discontinuation,31 prior immunomodulator failure29) |
Other |
• Male sex (HR 3.7 [1.9–7.4])34 |
• Elevated/detectable IFX trough levels34 |
Identified as risk factor of relapse for UC.